Research Groups

Mechanisms of Carcinogenesis - Epigenetics Group

Previous Publications - All publications 2012-2013

1. Nogueira da Costa A., Herceg Z. (2012) Detection of cancer-specific epigenomic changes in biofluids: Powerful tools in biomarker discovery and application Mol Oncol; 6(6):704-715. PMID: 22925902

2. Siouda M., Yue J., Shukla R., Guillermier S., Herceg Z., Creveaux M., Accardi R., Tommasino M., Sylla B.S. (2012) Transcriptional Regulation of the Human Tumor Suppressor DOK1 by E2F1 Molecular and cellular biology; 32(23):4877-4890. PMID: 23028047

3. Kesminiene A., Evrard A.S., Ivanov V.K., Malakhova I.V., Kurtinaitise J., Stengrevics A., Tekkel M., Chekin S., Drozdovitch V., Gavrilin Y., Golovanov I., Kryuchkov V.P., Maceika E., Mirkhaidarov A.K., Polyakov S., Tenet V., Tukov A.R., Byrnes G., Cardis E. (2012) Risk of Thyroid Cancer among Chernobyl Liquidators Radiation research; 178(5):425-436. PMID: 22998226

4. Mahabir S., Aagaard K., Anderson L.M., Herceg Z., Hiatt R.A., Hoover R.N., Linet M.S., Medina D., Potischman N., Tretli S., Trichopoulos D., Troisi R. (2012) Challenges and opportunities in research on early-life events/exposures and cancer development later in life Cancer causes & control : CCC; 23(6):983-990. PMID: 22527169

5. Saulnier A., Vaissiere T., Yue J., Siouda M., Malfroy M., Accardi R., Creveaux M., Sebastian S., Shahzad N., Gheit T., Hussain I., Torrente M., Maffini F.A., Calabrese L., Chiesa F., Cuenin C., Shukla R., Fathallah I., Matos E., Daudt A., Koifman S., Wunsch-Filho V., Menezes A.M., Curado M.P., Zaridze D., Boffetta P., Brennan P., Tommasino M., Herceg Z., Sylla B.S. (2012) Inactivation of the putative suppressor gene DOK1 by promoter hypermethylation in primary human cancers International journal of cancer; 130(11):2484-2494. PMID: 21796618

6. Xu X., Gammon M.D., Hernandez-Vargas H., Herceg Z., Wetmur J.G., Teitelbaum S.L., Bradshaw P.T., Neugut A.I., Santella R.M., Chen J. (2012) DNA methylation in peripheral blood measured by LUMA is associated with breast cancer in a population-based study FASEB journal; 26(6):2657-2666. PMID: 22371529

7. Kaur P., Mani S., Cros M.P., Scoazec J.Y., Chemin I., Hainaut P., Herceg Z. (2012) Epigenetic silencing of sFRP1 activates the canonical Wnt pathway and contributes to increased cell growth and proliferation in hepatocellular carcinoma Tumour biology; 33(2):325-336. PMID: 22351518

8. Mani S., Szymanska K., Cuenin C., Zaridze D., Balassiano K., Lima S.C., Matos E., Daudt A., Koifman S., Filho V.W., Menezes A.M., Curado M.P., Ferro G., Vaissiere T., Sylla B.S., Tommasino M., Pinto L.F., Boffetta P., Hainaut P., Brennan P., Herceg Z. (2012) DNA methylation changes associated with risk factors in tumors of the upper aerodigestive tract Epigenetics; 7(3):270-277. PMID: 22430803

9. Zoldos V., Horvat T., Novokmet M., Cuenin C., Muzinic A., Pucic M., Huffman J.E., Gornik O., Polasek O., Campbell H., Hayward C., Wright A.F., Rudan I., Owen K., McCarthy M.I., Herceg Z., Lauc G. (2012) Epigenetic silencing of HNF1A associates with changes in the composition of the human plasma N-glycome Epigenetics; 7(2):164-172. PMID: 22395466

10. Martin M., Herceg Z. (2012) From hepatitis to hepatocellular carcinoma: a proposed model for cross-talk between inflammation and epigenetic mechanisms Genome Med; 4(1):8. PMID: 22293089